Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jun 2026 and Jul 2026.
- Largest single sale: $2.0M (130,000 shares) of MoonLake Immunotherapeutics on Dec 8, 2025. Filing
- Last sale before this period: Feb 28, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Chief Scientific Officer | Apr 15, 2022 | Jul 29, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 27, 2026, MoonLake Immunotherapeutics: sold 1,100 shares for $22K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jul 22, 2026, MoonLake Immunotherapeutics: sold 2,448 shares for $49K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jul 21, 2026, MoonLake Immunotherapeutics: sold 50,000 shares for $1.0M, under a disclosed plan (some held indirectly). 1 filing: 1
- Jul 20, 2026, MoonLake Immunotherapeutics: sold 43,700 shares for $878K, under a disclosed plan (some held indirectly). 1 filing: 1
- Jul 15, 2026, MoonLake Immunotherapeutics: sold 16,105 shares for $322K, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.